| Mrs Megan Elizabeth Lupa, PA-C | |
|
751 Ne Blakely Dr, Suite 4020, Issaquah, WA 98029-6201 | |
| (425) 313-7124 | |
| (425) 313-7072 |
| Full Name | Mrs Megan Elizabeth Lupa |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 11 Years |
| Location | 751 Ne Blakely Dr, Issaquah, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346671070 | NPI | - | NPPES |
| 1346671070 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AS0400X | Physician Assistant - Surgical | PA60729756 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Swedish Issaquah | Issaquah, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Swedish Health Services | 0244138196 | 834 |
News Archive
Practicing non-pharmaceutical interventions such as hand-washing and mouth covering may help limit the transmission of the pandemic flu, but more research on these measures is critical according to a new study appearing in the May issue of AJIC: American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology, Inc.
Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that revenues in the second quarter of 2010 increased 36 percent versus revenues in the second quarter of 2009.
A new paper describes the effects of various non-pharmaceutical interventions in dealing with the spread of this virus among students, faculty, and staff on university campuses following the reopening of these institutions.
Oncolytics Biotech Inc. today announced that interim data from a Phase 2 clinical trial using intravenous administration of REOLYSIN® in combination with gemcitabine (Gemzar) in patients with advanced pancreatic cancer (REO 017) indicated that the clinical study had successfully reached its primary endpoint, and that the drug combination is active.
EpiCept Corporation today announced the commercial launch of Ceplene (R) (histamine dihydrochloride) in Germany. The launch is being conducted by Meda AB, as part of an exclusive commercialization agreement for Ceplene signed by the two companies in January 2010.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Megan Elizabeth Lupa, PA-C Po Box 25608, Salt Lake City, UT 84125-0608 Ph: (206) 320-4476 | Mrs Megan Elizabeth Lupa, PA-C 751 Ne Blakely Dr, Suite 4020, Issaquah, WA 98029-6201 Ph: (425) 313-7124 |
News Archive
Practicing non-pharmaceutical interventions such as hand-washing and mouth covering may help limit the transmission of the pandemic flu, but more research on these measures is critical according to a new study appearing in the May issue of AJIC: American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology, Inc.
Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that revenues in the second quarter of 2010 increased 36 percent versus revenues in the second quarter of 2009.
A new paper describes the effects of various non-pharmaceutical interventions in dealing with the spread of this virus among students, faculty, and staff on university campuses following the reopening of these institutions.
Oncolytics Biotech Inc. today announced that interim data from a Phase 2 clinical trial using intravenous administration of REOLYSIN® in combination with gemcitabine (Gemzar) in patients with advanced pancreatic cancer (REO 017) indicated that the clinical study had successfully reached its primary endpoint, and that the drug combination is active.
EpiCept Corporation today announced the commercial launch of Ceplene (R) (histamine dihydrochloride) in Germany. The launch is being conducted by Meda AB, as part of an exclusive commercialization agreement for Ceplene signed by the two companies in January 2010.
› Verified 1 days ago
Mr. Daniel Nathan Lindner, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 5708 E Lake Sammamish Pkwy Se, Issaquah, WA 98029 Phone: 425-688-5488 | |
Larissa Quadracci Mattei, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 510 8th Ave Ne Ste 200, Issaquah, WA 98029 Phone: 253-392-3030 Fax: 425-392-2564 | |
Charlie L Phu, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 751 Ne Blakely Dr Ste 4020, Issaquah, WA 98029 Phone: 425-313-4000 | |
Mr. Karl Frederick Kundert Jr., PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 450 Nw Gilman Blvd, Suite 205, Issaquah, WA 98027 Phone: 425-391-3737 Fax: 425-392-1510 | |
Blake J. Beck, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 510 8th Ave Ne Ste 310, Issaquah, WA 98029 Phone: 425-462-5006 Fax: 425-462-5019 | |
Mrs. Alexandria Becker, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 751 Ne Blakely Dr Ste 3020, Issaquah, WA 98029 Phone: 206-861-8550 Fax: 206-861-8551 | |
Josiah Odhiambo Owinyo, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 751 Ne Blakely Dr Ste 4020, Issaquah, WA 98029 Phone: 425-313-7124 |